The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast agents during MRI scans. Emerging research suggests gadolinium-based contrast agents, injected in a patient’s veins to brighten tissues in MRI images, accumulate in the brain. More than 300 million doses of such drugs have been administered since their introduction in 1987.

Via:: https://phys.org/news/2017-08-mri-contrast-agents-accumulate-brain.html

MRI contrast agents accumulate in the brain

Leave a Reply